Papers
8
Total Citations
166
H-Index
7
About
Dr. Samer A. Naffouje is a pioneering surgical oncologist whose research focuses on advancing minimally invasive techniques for complex gastrointestinal and thoracic malignancies, particularly esophageal and pancreatic cancers. His major contributions center on rigorously comparing robotic, laparoscopic, and open surgical approaches to determine optimal patient outcomes. Through large-scale, propensity-matched analyses of national databases, Dr. Naffouje has demonstrated that robotic and laparoscopic pancreatoduodenectomy and esophagectomy can achieve oncologic outcomes comparable to open surgery, while potentially reducing recovery times. His landmark 2019 study on Ivor-Lewis esophagectomy (42 citations) and 2020 analysis of 350 robotic-assisted esophagectomies (26 citations) have helped establish safety benchmarks for these advanced procedures. Notably, his 2024 work comparing robotic versus laparoscopic Whipple procedures (32 citations) addresses the critical learning curve impact on surgical quality. Dr. Naffouje’s research also explores operative time effects and return to intended oncologic therapy, providing actionable insights for surgeons adopting minimally invasive techniques. With over 160 cumulative citations across his most influential papers, his work is shaping the evidence base for the next generation of cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8